Millennium Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Millennium Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-336,463	Closed	-$3.63M	–	3860
2016 Q2	$3.63M	Sell	336,463 -140,455	-29%	-$1.2M	0.01%	1452
2016 Q1	$3.16M	Sell	476,918 -396,518	-45%	-$3.61M	0.01%	1529
2015 Q4	$15.8M	Buy	873,436 +114,981	+15%	+$1.58M	0.03%	664
2015 Q3	$8.35M	Sell	758,455 -4,969	-0.7%	-$52.8K	0.02%	1034
2015 Q2	$11M	Buy	763,424 +586,932	+333%	+$7.97M	0.02%	926
2015 Q1	$2.07M	Buy	176,492 +162,676	+1,177%	+$2.19M	﹤0.01%	1920
2014 Q4	$230K	Sell	13,816 -62,808	-82%	-$918K	﹤0.01%	3532
2014 Q3	$585K	Buy	+76,624	New	+$596K	﹤0.01%	2659

Other funds holding VTAE

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management's VTAE Position: Q3 2016 in Review

Millennium Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 336,463 shares — an estimated $3.63M sold.

Millennium Management first reported a position in VTAE in Q3 2014 and held it in 8 quarters. The position peaked at $15.8M in Q4 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

Millennium Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Millennium Management sold 336,463 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $3.63M.
Millennium Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 8 quarters.
Millennium Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $15.8M in Q4 2015.
98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Millennium Management's 13F filing for Q3 2016, filed 14 Nov 2016.